These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 23144924)
1. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. Bao R; Christova T; Song S; Angers S; Yan X; Attisano L PLoS One; 2012; 7(11):e48670. PubMed ID: 23144924 [TBL] [Abstract][Full Text] [Related]
2. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Ma L; Wang X; Jia T; Wei W; Chua MS; So S Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473 [TBL] [Abstract][Full Text] [Related]
3. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443 [TBL] [Abstract][Full Text] [Related]
4. Tanaka N; Mashima T; Mizutani A; Sato A; Aoyama A; Gong B; Yoshida H; Muramatsu Y; Nakata K; Matsuura M; Katayama R; Nagayama S; Fujita N; Sugimoto Y; Seimiya H Mol Cancer Ther; 2017 Apr; 16(4):752-762. PubMed ID: 28179481 [TBL] [Abstract][Full Text] [Related]
5. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta. Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278 [TBL] [Abstract][Full Text] [Related]
6. Evidence for tankyrases as antineoplastic targets in lung cancer. Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines. Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251 [TBL] [Abstract][Full Text] [Related]
9. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752 [TBL] [Abstract][Full Text] [Related]
10. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2. Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743 [TBL] [Abstract][Full Text] [Related]
11. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Mizutani A; Yashiroda Y; Muramatsu Y; Yoshida H; Chikada T; Tsumura T; Okue M; Shirai F; Fukami T; Yoshida M; Seimiya H Cancer Sci; 2018 Dec; 109(12):4003-4014. PubMed ID: 30238564 [TBL] [Abstract][Full Text] [Related]
12. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt. Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726 [TBL] [Abstract][Full Text] [Related]
13. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Wu X; Luo F; Li J; Zhong X; Liu K Int J Oncol; 2016 Apr; 48(4):1333-40. PubMed ID: 26820603 [TBL] [Abstract][Full Text] [Related]
14. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753 [TBL] [Abstract][Full Text] [Related]
15. Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase. Jang MK; Mashima T; Seimiya H Mol Cancer Ther; 2020 Mar; 19(3):765-776. PubMed ID: 31907221 [TBL] [Abstract][Full Text] [Related]